1Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.
2Department of Internal Medicine, Graduate School, Kyung Hee University, Seoul, Korea.
3Division of Medical Oncology and Hematology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.
4Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.
© Copyright 2017. Korean Association for the Study of Intestinal Diseases.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
No. | Sex/age (yr) | Interval from CD | Location of CD | CD treatment | Diagnosis | Monoclonal Ig subtype | Treatment | Reference |
---|---|---|---|---|---|---|---|---|
1 | F/66 | 14 yr | Ileum | Resection | Plasmacytoma | Not specified | NA | [7] |
2 | M/66 | 30 yr | Ileum | SAS, resection | MM | Not specified | NA | [8] |
3 | M/36 | 45 mo | Total colon, ileum | Observation | MM | IgG, λ | NA | [9] |
4 | M/45 | NA | Total colon, ileum | Resection | Plasmacytoma | Not specified | NA | [10] |
5 | F/59 | 9 yr | Total colon | Observation | MM | IgG, κ | Prednisolone | [11] |
6 | F/50 | 5 yr | Small bowel, colon | AZA, 6-MP, IFX | MM | IgG, κ | VAD, ASCT | [1] |
7 | M/50 | 6 yr | Small bowel | Resection | MM | IgG, λ | VAD, ASCT | [12] |
8 | M/36 | 15 yr | Total colon | AZA, SAS, IFX, ADA | SMM | IgA, κ | Observation | Current study |
No. | Sex/age (yr) | Interval from CD | Location of CD | CD treatment | Diagnosis | Monoclonal Ig subtype | Treatment | Reference |
---|---|---|---|---|---|---|---|---|
1 | F/66 | 14 yr | Ileum | Resection | Plasmacytoma | Not specified | NA | [ |
2 | M/66 | 30 yr | Ileum | SAS, resection | MM | Not specified | NA | [ |
3 | M/36 | 45 mo | Total colon, ileum | Observation | MM | IgG, λ | NA | [ |
4 | M/45 | NA | Total colon, ileum | Resection | Plasmacytoma | Not specified | NA | [ |
5 | F/59 | 9 yr | Total colon | Observation | MM | IgG, κ | Prednisolone | [ |
6 | F/50 | 5 yr | Small bowel, colon | AZA, 6-MP, IFX | MM | IgG, κ | VAD, ASCT | [ |
7 | M/50 | 6 yr | Small bowel | Resection | MM | IgG, λ | VAD, ASCT | [ |
8 | M/36 | 15 yr | Total colon | AZA, SAS, IFX, ADA | SMM | IgA, κ | Observation | Current study |
F, female; NA, not available; M, male; SAS, sulfasalazine; MM, multiple myeloma; AZA, azathioprine; 6-MP, mercaptopurine; IFX, infliximab; VAD, vincristine adriamycin dexamethasone; ASCT, autologous stem cell transplantation; ADA, adalimumab.
F, female; NA, not available; M, male; SAS, sulfasalazine; MM, multiple myeloma; AZA, azathioprine; 6-MP, mercaptopurine; IFX, infliximab; VAD, vincristine adriamycin dexamethasone; ASCT, autologous stem cell transplantation; ADA, adalimumab.